Glenmark introduces higher strength of FabiFlu to reduce pill burden of Covid-19 treatment

Aug 06, 2020

Mumbai (Maharashtra) [India], Aug 6 : Glenmark Pharmaceuticals will introduce a 400 mg version of oral anti-viral FabiFlu for the treatment of mild to...

Dr Reddy's launches Avigan (Favipiravir) for COVID-19 treatment

Aug 19, 2020

Hyderabad (Telangana) [India], Aug 19 : Dr Reddy's Laboratories on Wednesday announced the launch of Avigan (Favipiravir) 200 mg tablets in India for treatment...

Lupin launches Favipiravir in India for COVID treatment at Rs 49 per tablet

Aug 05, 2020

Mumbai (Maharashtra) [India], Aug 5 : Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt...

Zenara Pharma launches Paxzen tablet against mild to moderate COVID

Sep 09, 2022

Hyderabad (Telangana) [India], September 9 : Hyderabad-based Zenara Pharma, has announced that it has launched Nirmatrelvir and Ritonavir tablets in a combi pack as...

Sun Pharma launches Favipiravir in India for Rs 35 per tablet

Aug 04, 2020

Mumbai (Maharashtra) [India], Aug 4 : Sun Pharmaceutical Industries said on Tuesday it has launched Favipiravir (200 mg) in India under the brand FluGuard...

Glenmark introduces higher strength (400 mg) of FabiFlu® to reduce the pill burden of COVID-19 treatment

Aug 06, 2020

Mumbai (Maharashtra) [India] Aug 6 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a 400 mg version...